Helicobacter pylor is associated with an inflammatory reaction in the stomach and duodenum, yet the mechanism of this inflammatory infiltrate is unknown. The ability of Helicobacter pylon to secrete a factor that attracts leucocytes is investigated. Helicobacterpylori conditioned supernatant attracted neutrophils and monocytes with 50-100% of the activity of control chemotactic factor, 10-8M formyl-methionine-leucine-phenylalanine. Strains derived from individuals with ulcer or non-ulcer associated H pylori infections displayed similar chemotactic activity. Preliminary characterisation shows that the factor has a molecular weight of less than 3000, is heat stable, is acid resistant, and can be diluted at least 10-fold. Checkerboard analysis confirmed that the activity was chemotactic rather than chemokinetic. This chemotactic activity could play a role in the pathogenesis ofHelicobacter pylori gastritis. (Gut 1992; 33: Human leucocytes were obtained from heparinised peripheral blood by Ficoll-Hypaque density gradient separation (Histopaque, Sigma, St Louis, Missouri, USA) to obtain mononuclear cells, followed by dextran sedimentation to obtain neutrophils.6 The cells were washed and resuspended at a concentration of 106 monocytes or neutrophils/ml in Hanks balanced salt solution containing 0-15% bovine serum albumin.
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Helicobacter pyloni is strongly associated with superficial antral gastritis.' There is growing evidence that Helicobacter pylori is the causal agent of this inflammation.2 Bacteria are rarely seen in the setting of histologically normal antral mucous. Microscopic examination of infected gastric tissue shows H pylori on the gastric luminal side of the mucosa, in and beneath the mucus layer, and with an inflammatory infiltrate just below an intact gastric mucosa. 3 There is a strong correlation between the severity of the inflammation and the number of bacteria seen.2 Gastritis resolves after eradication of the bacterial infection.3 Based on these observations we sought to determine if Helicobacter pylori secretes a factor that attracts leucocytes. Many bacteria have been shown to secrete such factors, often characterised as low molecular weight, amino-formylated peptides.' The prototype is formyl-methionine-leucine-phenylalanine or f-met-leu-phe, a tripeptide isolated from E coli. 1B) . Figure 2 shows the chemotactic activity of Helicobacter pylori strains isolated from patients with active ulcer disease, compared with strains isolated from patients without ulcer disease. All strains tested produced neutrophil and monocyte chemotactic activity. The non-ulcer derived strains produced similar chemotactic activity as the ulcer derived H pylori strains.
The time course of chemotactic factor production is shown in Figure 3 . Chemotactic activity was evident by one hour after washing and resuspending the organisms at 107 bacteria/ml in phosphate buffered saline and remained active for at least 18 hours of incubation. Colony counts were performed on the bacteria after incubation, and there was no change in the number of bacteria from nought to four hours, when chemotactic activity became apparent. At 18 hours, more than half of the bacteria had died. These data suggest that chemotactic activity becomes apparent before there is any change in Preliminary characterisation of the Helicobacter pylori chemotactic factor has shown that the activity of the H pyloni supernatant is unaffected by boiling for 30 minutes, freezing overnight, lowering the pH of the supernatant from 6v7 to 2-0 for 30 minutes, or raising the pH from 6*7 to 10*0 for 30 minutes. Molecular sizing studies using Amicon ultrafiltration membranes (Amicon, Danvers, Mass, USA) showed that the chemotactic activity passed through membranes with pore sizes which excluded molecules of 10000 and 3000 molecular weight suggesting that the factor has a molecular weight of less than 3000 (Fig 4) 4 The gastric barrier against peptides in vivo includes mucosal carboxypeptidase. Whether chemotactic peptides can permeate an intact gastric mucosa is not known, however, luminal perfusion of the terminal ilium of rats with FMLP (10-6 M) produces signs of acute inflammation.'5 16 Formyl-methionine-leucinephenylalanine has also been shown to elicit neutrophil chemotaxis across epithelial monolayers in vitro with resultant disruption of epithelial barrier function,'7 and increased blood flow and vascular permeability in rat small intestine. 18 Further studies are underway to characterise and purify this chemotactic factor in order to help determine its role in the inflammatory response associated with Helicobacter pylori gastritis. The role the chemotactic factor may be playing in the development of H pylon related peptic ulcer disease is unclear. Our preliminary data indicating no difference in the production of the chemotactic activity between the ulcer derived and non-ulcer derived strains suggest that the chemotactic factor is unlikely to have a direct ulcerogenic effect, although secondary effects related to the release of inflammatory mediators may be involved. A more likely role for this chemotactic activity is in the production of the H pylon related gastritis with the recruitment of the inflammatory cells into the stomach wall. How the variations in the inflammatory responses seen on biopsy in epidemiological studies of Helicobacter pylori gastritis, and the variations in the clinical findings, relate to differences in the type or concentration of the chemotactic factor, and how these relate to mucosal or other host factors is unknown at this time.
